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Abstract: A number of viruses within the Peribunyaviridae family are naturally occurring reassortants,
a common phenomenon for segmented viruses. Using a minigenome-reporter and virus-like particle
(VLP) production assay, we have accessed the potential of Oropouche virus (OROV), Schmallenberg
virus (SBV), and other orthobunyaviruses within the Simbu serogroup to reassort. We found that the
untranslated region (UTR) in the medium segment is a potential contributing factor for reassortment
by the tested viruses. We demonstrate that for promoter activity to occur it was essential that the
viral RNA polymerase (L) and nucleocapsid (N) proteins were from the same virus, reinforcing the
hypothesis that the large and small segments that encode these proteins segregate together during
genome reassortment. Our results indicate that, given the right epidemiological setting, reassortment
between SBV and OROV would potentially be feasible and could contribute to the emergence of a
new Simbu virus.
Keywords: Oropouche virus; Schmallenberg virus; bunyavirus; Orthobunyavirus; Simbu serogroup;
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1. Introduction
The Orthobunyavirus genus in the Peribunyaviridae family (order Bunyavirales) comprises at least
30 viruses that can cause disease in humans and animals, including Oropouche virus (OROV),
Schmallenberg virus (SBV) and La Crosse virus (LACV) [1,2]. The Orthobunyavirus genome is tripartite,
made up of single-stranded segments of negative-sense polarity. The small genome segment encodes
the nucleocapsid (N) protein and, in a majority of viruses, an additional nonstructural protein called
NSs from an overlapping reading frame. The medium segment encodes a protein precursor for two
envelope glycoproteins (Gn and Gc) and a nonstructural protein called NSm. The large genome
segment encodes the RNA-dependent RNA polymerase (L protein). The 5′ and 3′ ends of these
genome segments are flanked by highly conserved and complementary genus-specific sequences,
which contain signals for genome transcription, replication, and packaging. Each genomic segment in
combination with the N and L proteins form a functional ribonucleoprotein (RNP) [2–6].
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The segmented nature of the bunyavirus genome potentially allows for easy reassortment between
its different members, a fact that was eloquently proposed a few years ago [7]. This phenomenon
of viral reassortment is well documented for viruses with segmented-genomes and occurs when
two genetically related viruses co-infect the same host cell. Known orthobunyavirus reassortants
include Apeu virus [8], Aino virus [9], Ngari virus [10], Iquitos virus [11], Madre de Dios virus [12]
and Perdoes virus [13]. Bunyavirus reassortants tend to contain small and large segments from the
same parental virus, whilst the medium segment donor remains, in most cases, unknown. Since the
small and large segments encode the N protein and the viral polymerase (L), which are essential for
genome replication, it is likely that they also co-evolve together [4,14]. The medium segment, on the
other hand, encodes the Gn and Gc, which bind to the attachment and entry receptors on the host cell.
Progeny viruses that arise from medium segment reassortment would therefore contain new genetic
information, potentially changing the tissue and/or host tropism of that virus [4,7].
To investigate whether OROV and SBV, both important pathogens in the Orthobunyavirus genus,
could reassort, we utilised a minigenome and virus-like particle assay to test their protein-protein
and protein-RNA interactions. OROV and SBV are both midge-borne and are classified in the Simbu
serogroup. Whilst OROV causes a febrile illness in humans in South America [15,16], SBV is responsible
for ruminant fetal malformations in Europe [17,18]. Separated by host and geographic distance,
these viruses are ideal for studying the determinants of cross-species transmission. Our study also
demonstrates how a combination of minigenome and virus-like particle assays can be used to predict
reassortment amongst bunyaviruses, without the requirement to generate infectious virus.
2. Materials and Methods
2.1. Cells
BSR-T7/5 cells, which stably express T7 RNA polymerase [19] were grown in Glasgow minimal
essential medium (GMEM, Invitrogen, UK) supplemented with 10% fetal bovine serum (FBS,
Invitrogen), 10% tryptose phosphate broth (TPB, Invitrogen), and 1 mg/mL G418 (Geneticin,
Invitrogen). BHK-21 cells were grown in GMEM supplemented with 10% newborn calf serum (NCS,
Invitrogen) and 10% TPB. Both cell lines were grown and maintained at 37 ◦C with 5% CO2.
2.2. Plasmids
Minigenome-expressing and protein-expressing plasmids for OROV, SBV, and Bunyamwera virus
(BUNV) have been previously described [6,18,20–22]. Plasmids pTM1OROV-L, pTM1OROV-M, and
pTM1OROV-N for OROV; pTM1SBV-L, pTM1SBV-M and pTM1SBVN for SBV; and pTM1BUNV-L,
pTM1BUNV-M and pTM1BUNV-N for BUNV express the viral polymerase, glycoproteins Gn
and Gc, and the N protein under the control of a T7 promoter and the internal ribosomal entry
site (IRES), from encephalomyocarditis virus (EMCV) [23]. Nucleotide substitutions to generate
OROV M-minigenome-(8A/A 9A/A) and SBV M-minigenome-(8T/A 9C/A) were introduced by
QuikChange site-directed mutagenesis (Stratagene, UK). The minigenome plasmids TVT7RSBVLRen(-)
and pTVT7AKVMRen(-) were generated as previously described in [20]. The coding sequences of
SBV large [18] and Akabane virus (AKV) medium segments (Plasmid donated by Massimo Palmarini,
Centre for Virus Research, University of Glasgow, UK) in the pTVT7 plasmids were deleted by
excision PCR (KOD Hot Start DNA polymerase; Merck, UK), leaving the untranslated region (UTR)
intact and used as a vector to clone in the Renilla luciferase coding sequence as in [20]. Plasmids
pTVT7OYAMRen(-) and pTVT7PEDMRen(-), which contain Oya virus (OYAV) and Perdoes virus M
UTRs, were generated using pTVT7Ren(-) as a template. This plasmid generates T7 transcripts
containing Renilla luciferase in the negative sense. Oligonucleotides containing the sequences
corresponding to either the 5′ UTR or 3′ UTR of OYAV or Perdoes virus were then cloned in with
excision PCR (KOD Hot Start DNA polymerase; Merck) and In-Fusion HD Cloning (Clonetech,
Takara Bio, UK) techniques. This approach of synthetically cloning in the UTR sequences for OYAV
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and Perdoes virus was adopted due to the unavailability of viral stocks or plasmids for either virus.
Oligonucleotides were based on sequences in GenBank.
2.3. Minigenome Assay
5 × 104 BSR-T7/5 cells/mL in 24-well trays were transfected with the desired amount of
protein-expressing plasmids, 125 ng of a minigenome-expressing plasmid and 25 ng pTM1-FF-Luc
using Lipofectamine 2000 (Invitrogen, UK), as per the manufacturer’s instructions. The amount of
DNA in each well was kept constant by the addition of empty vector, pTM1. To normalize transfection
efficiencies, cells were co-transfected with firefly luciferase expression plasmid pTM1-FF-luc, allowing
induction levels of Renilla luciferase to be calculated [21]. At 24 h post-transfection (p.t.), cells were
washed with 0.5 mL of phosphate buffered saline (PBS) and then lysed using 100 µL Passive lysis
buffer from the Promega Dual-Luciferase Reporter Assay kit (Promega, UK). The rest of the assay
was carried out as per the manufacturer’s recommendations. Readings were measured on a GloMax
20/20 luminometer (Promega).
2.4. Virus-Like Particle Production Assay
1.5 × 105 BSR-T7/5 cells/mL in 12-well trays were transfected with 500 ng of pTM1-L and
pTM1-N, 125 ng of a minigenome-expressing plasmid, and 25 ng pTM1-FF-Luc. At 24 h p.t., Renilla
and firefly luciferase activities were measured using Dual-Luciferase Reporter Assay kit (Promega).
To generate virus-like particles (VLPs), the minigenome transfection mix was supplemented with
200 ng pTM1-M. At 48 h p.t., supernatants were harvested, clarified by centrifugation (1400 g for 5 min),
digested with benzonase (≥250 units/µL, Novagen, UK), and used to infect either BSR-T7/5 cells that
were pre-transfected with 1 µg of pTM1-L, pTM1-N and pTM1-M for 24 h, or untransfected BHK-21
cells. Renilla activity was measured after 24 h using the Dual-Luciferase Reporter Assay kit (Promega).
3. Results
3.1. Schmallenberg virus N and L Proteins Are Capable of Transcribing and Replicating Oropouche
Virus Minigenomes
To assess whether the N and L proteins of SBV recognise and initiate transcription and replication
of the OROV minigenome, and vice versa, we compared minigenome activity with a combination of
homologous and/or heterologous N and L proteins. To do this, we transfected BSR-T7/5 cells
with OROV or SBV medium segment minigenomes (M-minigenome) with either the N and L
protein-expressing plasmids of the respective virus or a combination of OROV and SBV N and
L (Figure 1A).
The minigenome plasmids contain the Renilla luciferase reporter gene flanked by viral UTRs, in
the viral genomic (negative) sense, hence functioning as a genome segment analogue. Replication
and transcription of this minigenome is initiated only when the N and L proteins can recognise the
viral UTR as a functional promoter. This then leads to the expression of Renilla luciferase. As expected,
minigenome activity was detected in the homologous minigenome systems (i.e., OROV M-minigenome
with OROV N-L or SBV M-minigenome with SBV N-L) (Figure 1A). Interestingly, a greater than 50-fold
increase in minigenome activity was also detected in OROV M-minigenome with SBV N-L, contrasting
a less than 10-fold increase over background in SBV M-minigenome with OROV N-L (Figure 1A).
Furthermore, minigenome activity increased when the N and L protein pair came from the same virus,
in contrast to when heterologous N and L proteins were used (Figure 1A).
Since SBV N and L could recognise and support OROV M-minigenome transcription and
replication, we next tested their ability to utilise OROV small and large segment UTRs via S- and
L-minigenomes. As shown in Figure 1B, luciferase activity was detected from all three OROV
minigenomes, indicating that SBV N and L proteins were able to recognize the UTRs of all OROV
segments (Figure 1B). In short, the minigenome assays suggest that SBV polymerase can interact and
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recognise OROV UTRs and form a functional heterologous RNP consisting of SBV N and L proteins
and OROV minigenome.Viruses 2017, 9, 220 4 of 12 
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were transfected as previously described. 250 ng of pTM1SBV-N and/or pTM1SBV-L were transfected 
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(25 ng). At 24 h p.t., Renilla and firefly luciferase were measured using a Dual-Luciferase Reporter Assay 
kit (Promega). Luciferase values were normalized and minigenome-activity expressed as fold-induction 
over background control (no pTM1-L). Error bars indicate SD (n = 3). OROV, Oropouche virus; SBV, 
Schmallenberg virus; L, viral polymerase; N, nucleocapsid protein; M minigenome, medium segment 
analogue; L-UTR, large segment untranslated region; M-UTR, medium segment untranslated region; 
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transcription as previously described [24]. Positive samples were further tested on untransfected 
BHK-21 cells for confirmation (data not shown). As we expected, Renilla luciferase was detected 
from cells infected with OROV and SBV VLP controls (Figure 2A, bar 3 and Figure 2B, bar 6). 
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than SBV’s own VLP system (Figure 2B), which could just be down to an optimization efficiency of 
the SBV VLP system. A low signal was also observed for BUNV glycoprotein spiked VLP containing 
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Figure 1. Minigenome activity: (A) BSR-T7/5 cells were transfected with pTM1-N and/or pTM1-L
(250 ng) and M-minigenome (125 ng) plasmids, pTVT7R-SBVMRen(-), or pTVT7OROVMRen(-). Firefly
luciferase-expressing pTM1-FF-Luc (25 ng) served as a transfection control. At 24 h post-transfection
(p.t.), Renilla and firefly luciferase were measured using a Dual-Luciferase Reporter Assay kit (Promega).
Luciferase val es we e rmalized and m igenome- ctivity expressed as fold-induction over
background control (no pTM1-L). Error ars indicate standard deviation (SD; n = 3). (B) BSR-T7/5 cells
were transfected as previously described. 250 ng of pTM1SBV-N and/or pTM1SBV-L were transfected
with 125 ng of pTVT7OROVLRen(-), pTVT7OROVMRen(-), or pTVT7OROVSRen(-), and pTM1-FF-Luc
(25 ng). At 24 h p.t., Renilla and firefly luciferase were measured using a Dual-Luciferase Reporter Assay
kit (Promega). Luciferase values were normalized and minigenome-activity expressed as fold-induction
over backgr und control (no pTM1-L). Error bars i dicate SD (n = 3). OROV, Oropouche virus; SBV,
Schmallenberg virus; L, viral polymerase; N, nucleocapsid protein; M minigenome, medium segment
analogue; L-UTR, large segment untranslated region; M-UTR, medium segment untranslated region;
S-UTR, small segment untranslated region.
3.2. Packaging and Assembly of Heterologous Viral-Like Particles
To investigate whether the heterologous RNP can be packaged into viral particles, we examined
the formation of infectious VLPs (iVLPs) [22]. Here, BSR-T7/5 cells were transfected with either SBV
or OROV M-minigenome in combination with different viral N, L and M cDNA expression plasmids
(Figure 2A,B). The family p ototype Bu yamwera virus (BUNV) glycoprot in was also included as
a control. The formation of iVLP from transfected cells was examined by using that supernatant to
infect fresh BSR-T7/5 cells that were pre-transfected with N, L and M plasmids, in order to boost
transcription as previously described [24]. Positive samples were further tested on untransfected
BHK-21 cells for confirmation (data not shown). As we expected, Renilla luciferase was detected from
cells infected with OROV and SBV VLP controls (Figure 2A, bar 3 and Figure 2B, bar 6). Consistent
with the aforementioned minigenome assay, reporter activity was also detected from cells infected
with hybrid VLPs, i.e., OROV glycoproteins-spiked VLPs containing heterologous RNPs (OROV or
SBV M-minigenomes with SBV N-L) (Figure 2A,B, bar 5). However, no heterologous iVLP was formed
by the SBV glycoproteins with OROV M-minigeno e RNP and only low reporter activity was detected
from OROV M-minig nome-SBV N-L (Figure 2A,B, bar 4). Interes ingly, he VLPs with the OROV
glycoprotein spike and SBV RNPs generated a higher signal than SBV’s own VLP system (Figure 2B),
which could just be down to an optimization efficiency of the SBV VLP system. A low signal was also
observed for BUNV glycoprotein spiked VLP containing OROV or SBV minigenome with SBV N-L
(Figure 2).
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As the interaction between viral Gn cytoplasmic tail (CT) and N or RNP is crucial for bunyavirus
assembly [25], the results indicate that OROV Gn glycoprotein can interact with heterologous SBV
RNPs to assemble iVLPs. The efficient formation of infectious heterologous VLPs suggest that the
reassortment between OROV and SBV would likely lead to a new reassortant containing a combination
of small and large segments from SBV and a medium segment from OROV.
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Figure 2. Virus-like particl P) assay. (A,B) BSR-T7/5 cells were transfected with pTM1SBV-L
(200 ng) and pTM1SBV-N (400 ng) or pTM1OROV-L and pTM1OROV-N (400 ng), along with pTM1-M
(200 ng), and M-minigenome (200 ng) and pTM1-FF-Luc (40 ng). At 48 h p.t., clarified supernatant was
used to infect cells pre-transfected with protein-expressing plasmids only, as indicated. At 24 h p.t.,
luciferase readings were measured as described above. Renilla activity is expressed as fold induction
over control pTM1-N. Error bars indicate SD (n = 3). * p < 0.05 (pair-wise Student’s t-test). BUNV,
Bunyamwera virus; OROV, Oropouche virus; SBV, Schmallenberg virus; L, viral polymerase; N,
nucleocapsid protein; M, glycoprotein precursor; M minigenome, medium segment analogue.
3.3. The Importance of Untranslated Region Positions Eight and Nine
Since SBV N and L proteins were able to recognise OROV M UTR and not the other way around
we decided to investigate the sequence difference that may contribute to this UTR recognition. We
aligned the medium segment UTRs of OROV and SBV, along with that of other Simbu serogroup
viruses—Akabane virus (AKV), Oya virus (OYAV), Perdoes virus, and BUNV (Figure 3A). Interestingly,
SBV and AKV (another ruminant pathogen) contain 8A/A-9A/A “double-mismatch” at positions
eight and nine of the M UTR. This is a variation from the “typical” 8A/U-9C/A “pairing/mismatch”
present in OROV, BUNV, OYAV, and Perdoes virus. These positions have bee shown to be important
for orthobunyavirus promoter activity [3,20,26]. We n xt analysed the role these residu may play
in promoter recognition by the viral N and L prot ins. Th eighth and ninth nucleotides of OROV
M-minigenome (8A/U–9C/A) were altered to mimic the residues of SBV M-UTR (8A/A–9 /A),
resulting in the first 11 residues of OROV M-UTR being changed to those of SBV (Figure 3A).
A minigenome assay with the plasmid bearing this mutation (OROV M-minigenome 8A/A 9A/A)
resulted in a loss of UTR functionality with OROV N and L proteins and a decreased efficiency of UTR
functionality with SBV N and L proteins (Figure 3B; 8A/A, 9A/A). A similar approach using the SBV
M-minigenome was then carried out, where the first 11 residues of SBV M-UTR were altered to mimic
OROV M-UTR (8A/U 9C/A), however this change did not result in rescue of luciferase activity for
OROV N and L proteins (Figure 3C; 8U/A 9C/A). To test whether the terminal 11 nucleotides alone
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are sufficient for promoter activity, an OROV M-minigenome containing only the terminal 5′ and 3′
13 nucleotides was generated, however this minigenome with the truncated UTR was not functional
with either OROV or SBV N and L proteins (data not shown), consistent with previous work [27].The
length of the 3′ UTR of orthobunyaviruses vary considerably and, amongst the viruses focused on in
this study, AKV has the shortest 5′ UTR: only 22 nucleotides. Previous work has demonstrated that
the minimum requirement for a viable BUNV S segment mutant is a 22 nucleotide 5′ UTR, with at
least 112 nucleotides at the 3′ terminus [28].
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Figure 3. Analysis of the Simbu medium segment untranslated region (M UTR). (A) Sequence
comparison of the 3′ and 5′ panhandle nucleotides of the M segments of Oropouche virus (OROV)
(GenBank accession no, KP052851), Schmallenberg virus (SBV) [18], Bunyamwera virus (BUNV)
(GenBank accession no, NC_001926), Oya virus (OYAV) (GenBank accession no, JX983193), Akabane
virus (AKV) (GenBank accession no, NC_009895) and Perdoes virus (GenBank accession no, KP691628).
OROV, BUNV, OYAV, and Perdoes viruses contain a single mismatch at position nine (8A/U 9C/A),
whereas SBV and AKV contain a double mismatch at positions eight and nine (8A/A and 9A/A).
These mismatches have been highlighted in red in the sequence alignment. (B,C) Minigenome assays.
Performed as described above. Error bars indicate SD (n = 3).
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3.4. OROV N and L Proteins Are Capable of Transcribing and Replicating a Large Segment SBV Minigenome
The large segment UTRs of viruses OROV, SBV, BUNV, AKV, OYAV and Perdoes virus, in contrast
to their medium segment UTRs, contain identical nucleotides in the first eleven positions (Figure 4A).
The large segment UTR (L-UTR) of SBV and AKV do not contain the 8A/A–9A/A “double-mismatch”
at positions eight and nine that are present in their M UTR (Figure 3A). Instead the L UTR of SBV and
AKV possess the “typical” 8A/U 9C/A “pairing/mismatch”, similar to OROV, BUNV, OYAV and
Perdoes virus (Figure 4A). Thereby, we tested the SBV L segment promoter in a minigenome assay
with OROV or BUN N and L proteins. Interestingly, OROV and BUNV N and L were now able to
transcribe and replicate this SBV L-minigenome (Figure 4B). These results demonstrate that, in contrast
to SBV M-UTR (Figure 1A), the N and L proteins of OROV are capable of recognising and using SBV
L-UTR as a promoter.
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Figure 4. Analysis of Simbu large segment untranslated region (L UTR). (A) Sequence comparison
of the 3′ and 5′ panhandle nucleotides of the L segments from Oropouche virus (OROV) (GenBank
Accession no. KP052850), Schmallenberg virus (SBV) [18], Bunyamwera virus (BUNV) (GenBank
Accession no. NC_001925), Oya virus (OYAV) (GenBank Accession no. JX983194), Akabane virus
(AKV) (GenBank accession no, NC_009894) and Perdoes virus (GenBank Accession no. KP691627).
All viruses contain a single mi match at position nine (8 A/U 9C/A). These mismatches have been
highlighted in red in the sequence alignment. (B) Minigenome ssays. BSR-T7/5 cells were transfected
with OROV N-L, or SBV N-L, or BUN N-L (250 ng), and TVT7RSBVLRen(-) (125 ng) and pTM1-FF-Luc
(40 ng). At 24 h p.t., luciferase activity was measured and calculated and described above. Error bars
indicate SD (n = 3).
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3.5. Analysis of the Reassortment Potential amongst Various Simbu Serogroup Viruses
To further investigate the importance of the medium segments UTR in genomic reassortment,
we generated medium segment based minigenomes (M-minigenome) for AKV, OYAV, and Perdoes
virus (in a previous publication we describe Perdoes virus as a reassortant containing OROV S and L
segments [13]). The activity of these minigenome plasmids were then assessed using SBV, OROV or
BUNV N and L proteins. Briefly, BSR-T7/5 cells were transfected as previously described and reporter
activity, detected at 24 h p.t., OYAV and Perdoes virus M-minigenomes were functional with OROV,
SBV and BUN N and L (Figure 5), however reporter activity from AKV M-minigenome could only be
detected with SBV N and L (Figure 5B). The results also demonstrate that OROV and SBV N and L
proteins can transcribe and replicate BUNV M-minigenome (Figure 5A,B), whilst BUNV N and L can
transcribe and replicate OROV M-minigenome and to a less extent SBV M-minigenome (Figure 5C).
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4. Discussion
Segmented viruses carry the potential for genome reassortment, an important characteristic as this
allows these viruses to generate new strains and new virus species. This phenomenon, on occasions,
can result in the acquisition of new or increased pathogenic characteristics and, hence, understanding
molecular determinants driving reassortment can be beneficial for predicting the emergence of a new
virus. Additionally, the information gathered by studying reassortment may be applied to vaccine
development. There are currently no vaccines available for any member of the Orthobunyavirus genus
and vaccines based on attenuated viruses carry the risk of reverting back to pathogenicity due to
genetic exchange with naturally circulating wild-type strains. Hence, understanding factors that drive
reassortment will allow such vaccines to be implemented effectively.
Using minigenome systems, the current study focuses on SBV and OROV, two important
Simbu serogroup viruses of veterinary and public health importance. As expected, Renilla luciferase
activity was detected in both the OROV and SBV medium segment based minigenome systems (i.e.,
using the N and L proteins corresponding to their medium segment analogue, M-minigenome),
demonstrating the specificity of virus replication (Figure 1A). Unexpectedly, Renilla activity was
also detected when SBV N and L proteins were assayed with OROV M-minigenome, but not the
contrary. To confirm the minigenome results, a VLP assay was carried out. Bunyavirus assembly
and budding occurs via interactions between the Gn-CT and the RNP [22,25], hence, this forms
another important restricting factor for the emergence of new reassortant viruses. The VLP data
demonstrated that OROV glycoproteins and SBV-based RNPs are capable of forming iVLPs, whilst
SBV glycoproteins were unable to form transmissible/entry-competent VLPs with OROV-based
RNPs (Figure 2A, OROVN + OROVL + SBVM). These results are important as: (i) they can be taken as
confirmation that the minigenome assay results are valid, (ii) it supports the hypothesis that reassortant
SBV-OROV viruses could potentially be generated, and (iii) it is likely that the potential reassortant
virus would comprise of an OROV medium segment and SBV small and large segments. Our data
also indicates a possible restrictive association between heterologous Gn and N proteins, suggesting
that this interaction may be important for virus assembly. In phleboviruses (Phenuiviridae family), the
Gn CT acts as a matrix protein, bridging the RNA and glycoproteins for RNP trafficking and virus
assembly [25,29]. However, this specificity of the Gn CT and N protein/RNP interaction is not well
documented in orthobunyaviruses (Peribunyaviridae family).
The difference between the medium segment UTR nucleotide positions eight and nine of the
clade A Simbu viruses (OROV, OYAV, Perdoes) and the clade B Simbu viruses (SBV, AKV) is intriguing
and it is tempting to speculate that these two residues may play a part in determining reassortment.
The availability of complete orthobunyavirus sequences would be beneficial to allow a comprehensive
analysis of this region and to determine if there is any relevance towards the virus–host pairing.
For now at least, our results show that the N and L proteins of SBV exhibit a much broader UTR
recognition range as it successfully transcribed and replicated AKV, BUN, OROV, OYAV and Perdoes
virus M-minigenomes, unlike OROV or BUNV N and L (Figure 5; Table 1). This result would indicate
that even though closely related viruses may share a degree of conservation in their N and L proteins,
it is also the secondary structure of the medium segment UTR that drives their interaction. It has
been demonstrated for other bunyaviruses that the interaction between the viral promoter and its
polymerase is mediated by the nucleotide at position 8 of the 3′ UTR [3]. For La Crosse Virus (LACV),
this interaction occurs at the “clamp” region of the L protein, which interacts with the adenine
nucleotide at position 8. Interestingly, a majority of Simbu viruses including SBV and OROV possess a
deletion of an asparagine residue in this region, which could possibly change the interaction between
their L proteins and the promoter region of other bunyaviruses, reducing the specificity we observed in
our results [3]. By mutating the eighth and nineth nucleotides of OROV M-minigenome (8A/T–9C/A)
to mimic the residues of SBV M-UTR (8A/A–9A/A), we found that OROV N and L proteins lost their
ability to recognize and transcribe their own OROV M-promoter, whilst the efficiency of SBV N-L
decreased as well (Figure 3B). This is interesting because the downstream sequences in the OROV
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M-minigenome were unchanged, confirming previous results of the importance of this region in
promoter activity [20,27,30]. Further, changing SBV M-minigenome (8A/A 9A/A) to mimic OROV
medium segment UTR (8A/U 9C/A), with the rationale that if positions eight and nine of the M
UTRs are determinants for promoter activity, then maybe changing the SBV M-minigenome at these
positions could rescue minigenome activity with the OROV N and L proteins. However, this was not
the case (Figure 3C; OROV N-L, 8U/A 9C/A) and, instead, minigenome activity decreased, even with
SBV N and L proteins (Figure 3C, SBV N-L, 8U/A 9C/A). These results indicate that although the first
11 nucleotides are important, sequences beyond these residues are also essential for promoter activity.
Previous work on BUNV has shown that mutant viruses lacking large portions of the UTR close to the
coding-regions are highly attenuated due to diminished gene regulation [28,31,32].
Co-infection with bunyaviruses could theoretically result in eight potential genome combinations:
AAA, ABA, BAA, AAB, BBA, ABB, BAB and BBB (where AAA and BBB are parental viruses and
the combination arranged as SML segments) [7]. However, as the N (small segment product) and
L (large segment product) need to be from the same virus for genome replication and transcription
to occur, this substantially restricts viable reassortant combinations. The determining factor is then
based on recognition of the medium segment UTR in virus B by the N and L proteins of virus A. Our
data demonstrates that OROV N and L proteins are unable to use SBV medium segment promoter.
Therefore, in the case of OROV and SBV, it is likely that the only progeny reassortant that could arise
from these two viruses would contain SBV small and large segments with an OROV medium segment
(as SBV N-L proteins can use both OROV and SBV medium segment UTR as a promoter). Based
on these findings, out of the eight possible progeny viruses between OROV and SBV, there may in
fact be only one viable new reassortant, i.e., a virus with the small and large segments from SBV
and a medium segment from OROV. These results imply that the number of possible reassortants
in nature may not be as vast as we think and we propose that reassortment may be driven by the
medium segment.
Both OROV and SBV are transmitted by Culicoides midges, which have a wide geographic
distribution [33]. The spread of SBV outside of Europe is a threat to the cattle farming industry
and, in a setting such as Brazil, if geographic boundaries are broken, the possibility of OROV and
SBV replicating in the same vector population could arise, with the risk of reassortment. Arboviral
reassortants have been reported to arise in arthropod vectors, and it has been suggested that these
insects could have played a major role in the evolution and emergence of RNA viruses [34,35]. Taken
together, our data suggests that the emergence of a new reassortant virus containing the small and
large segments of SBV and the medium segment of OROV could potentially be a cause for a SBV
spillover into the human population.
Table 1. A summary of the medium segment based minigenomes (M-minigenome) that are functional
with either the N and L proteins of BUNV, OROV or SBV (
Polymers 2016, 8, 404  9 of 12 
 
 
Figure 11. Polypseudorotaxanes inter- or intra-crosslink with each other via hydrogen bonding.  
Table 2. Ten percent 10KPEGMA and 10% P-10K solutions with 10% α-CD. 
Sample Gel
10KPEGMA 
P-10K 
 
Figure 12. Pectin-PEGMA solution turned white after the addition of α-CD: (a) original 10% P-10K 
solution; and (b) 10% P-10K solution after the addition of α-CD (10%). 
indicates that Renilla activity was not
detected,4 indicates that Renilla activity was detected).
M-minigenome N and L Proteins
BUNV OROV SBV
Akabane virus (AKV)
Polymers 2016, 8, 404  9 of 12 
 
 
Figure 11. Polypseudorotaxanes inter- or intr -crosslink with each other via hydrogen bonding.  
Table 2. Ten percent 10KPEGMA and 10% P-10K solutions with 10% α-CD. 
Sample Gel
10KPEGMA 
P-10K 
 
Figure 12. Pectin-PEGMA solution turned white after the addition of α-CD: (a) original 10% P-10K 
solution; and (b) 10% P-10K solution after the addition of α-CD (10%). 
Polymers 2016, 8, 404  9 of 12 
 
 
Figure 11. Polypseudorotaxanes inter- or intra-crosslink with each other via hydrogen bonding.  
Table 2. Ten percent 10KPEGMA and 10% P-10K solutions with 10% α-CD. 
Sample Gel
10KPEGMA 
P-10K 
 
Figure 12. Pectin-PEGMA solu ion turne  white after the add tion of α-CD: (a) original 10% P-10K 
solution; and (b) 10% P-10K solution after the addition of α-CD (10%). 
4
Bunyamwera virus (BUNV) 4 4 4
Oropouche virus (OROV) 4 4 4
Oya virus (OYAV) 4 4 4
Perdoes virus 4 4 4
Schmallenberg virus (SBV) inefficient
Polymers 2016, 8, 404  9 of 12 
 
 
Figure 11. Polypseudorotaxanes inter- or intra-crosslink with each other via hydrogen bonding.  
Table 2. Ten percent 10KPEGMA and 10% P-10K solutions with 10% α-CD. 
Sample Gel
10KPEGMA 
P-10K 
 
Figure 12. Pectin-PEGMA solution turned white after the addition of α-CD: (a) original 10% P-10K 
solution; and (b) 10% P-10K solution after the addition of α-CD (10%). 
4
Viruses 2017, 9, 220 11 of 12
Acknowledgments: We would like to thank Massimo Palmarini for donating a plasmid containing Akabane virus
medium segment. We thank Andrew M. Tilston-Lunel for proof reading the manuscript.
Author Contributions: N.L.T.-L. and G.O.A. conceived the idea. R.M.E. provided initial input on the project.
N.L.T-L preformed the experiments. X.S set-up the SBV minigenome system. N.L.T.-L. and G.O.A. wrote the
manuscript. N.L.T.-L., G.O.A. and X.S. read, edited and approved the final manuscript. This work was supported
by a Wellcome Trust Senior Investigator Award to R.M.E. (099220/B/12/Z) and a Medical Research Council
postgraduate studentship to N.L.T.-L. (1101085). G.O.A. was supported by Sao Paulo Research Foundation
(FAPESP-BEPE grant 2013/02798-0).
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Elliott, R.M.; Blakqori, G. Molecular Biology of Orthobunyaviruses. In Bunyaviridae: Molecular and Cellular
Biology; Plyusnin, A., Elliott, R.M., Eds.; Caister Academic Press: Norfolk, UK, 2011.
2. Elliott, R.M.; Schmaljohn, C.S. Bunyaviridae. In Fields Virology; Knipe, D.M., Howley, P., Eds.; Lippincott
Williams & Wilkins: Philadelphia, PA, USA, 2013.
3. Gerlach, P.; Malet, H.; Cusack, S.; Reguera, J. Structural Insights into Bunyavirus Replication and Its
Regulation by the vRNA Promoter. Cell 2015, 161, 1267–1279. [CrossRef] [PubMed]
4. Elliott, R.M. Orthobunyaviruses: Recent genetic and structural insights. Nat. Rev. Microbiol. 2014, 12, 673–685.
[CrossRef] [PubMed]
5. Dong, H.; Li, P.; Bottcher, B.; Elliott, R.M.; Dong, C. Crystal structure of Schmallenberg orthobunyavirus
nucleoprotein-RNA complex reveals a novel RNA sequestration mechanism. RNA 2013, 19, 1129–1136.
[CrossRef] [PubMed]
6. Dong, H.; Li, P.; Elliott, R.M.; Dong, C. Structure of Schmallenberg orthobunyavirus nucleoprotein suggests
a novel mechanism of genome encapsidation. J. Virol. 2013, 87, 5593–5601. [CrossRef] [PubMed]
7. Briese, T.; Calisher, C.H.; Higgs, S. Viruses of the family Bunyaviridae: Are all available isolates reassortants?
Virology 2013, 446, 207–216. [CrossRef] [PubMed]
8. De Brito Magalhaes, C.L.; Drumond, B.P.; Novaes, R.F.; Quinan, B.R.; de Magalhaes, J.C.; dos Santos, J.R.;
Pinto Cdo, A.; Assis, M.T.; Bonjardim, C.A.; Kroon, E.G.; et al. Identification of a phylogenetically distinct
orthobunyavirus from group C. Arch. Virol. 2011, 156, 1173–1184. [CrossRef] [PubMed]
9. Yanase, T.; Aizawa, M.; Kato, T.; Yamakawa, M.; Shirafuji, H.; Tsuda, T. Genetic characterization of Aino and
Peaton virus field isolates reveals a genetic reassortment between these viruses in nature. Virus Res. 2010,
153, 1–7. [CrossRef] [PubMed]
10. Gerrard, S.R.; Li, L.; Barrett, A.D.; Nichol, S.T. Ngari virus is a Bunyamwera virus reassortant that can be
associated with large outbreaks of hemorrhagic fever in Africa. J. Virol. 2004, 78, 8922–8926. [CrossRef]
[PubMed]
11. Aguilar, P.V.; Barrett, A.D.; Saeed, M.F.; Watts, D.M.; Russell, K.; Guevara, C.; Ampuero, J.S.; Suarez, L.;
Cespedes, M.; Montgomery, J.M.; et al. Iquitos Virus: A Novel Reassortant Orthobunyavirus Associated
with Human Illness in Peru. PLoS Negl. Trop. Dis. 2011, 5. [CrossRef] [PubMed]
12. Ladner, J.T.; Savji, N.; Lofts, L.; Travassos da Rosa, A.; Wiley, M.R.; Gestole, M.C.; Rosen, G.E.; Guzman, H.;
Vasconcelos, P.F.; Nunes, M.R.; et al. Genomic and phylogenetic characterization of viruses included in the
Manzanilla and Oropouche species complexes of the genus Orthobunyavirus, family Bunyaviridae. J. Gen. Virol.
2014, 95, 1055–1066. [CrossRef]
13. Tilston-Lunel, N.L.; Hughes, J.; Acrani, G.O.; da Silva, D.E.; Azevedo, R.S.; Rodrigues, S.G.; Vasconcelos, P.F.;
Nunes, M.R.; Elliott, R.M. Genetic analysis of members of the species Oropouche virus and identification of
a novel M segment sequence. J. Gen. Virol. 2015, 96 Pt 7, 1636–1650. [CrossRef] [PubMed]
14. Iroegbu, C.U.; Pringle, C.R. Genetic interactions among viruses of the Bunyamwera complex. J. Virol. 1981,
37, 383–394. [PubMed]
15. Travassos da Rosa, J.F.; de Souza, W.M.; Pinheiro, F.d.P.; Figueiredo, M.L.; Cardoso, J.F.; Acrani, G.O.;
Nunes, M.R.T. Oropouche Virus: Clinical, Epidemiological, and Molecular Aspects of a Neglected
Orthobunyavirus. Am. J. Trop. Med. Hyg. 2017, 96, 1019–1030. [PubMed]
16. Tilston-Lunel, N.L. Oropouche virus: Poised for headlines? Biochem. Emerg. Dis. 2017, 39, 12–17.
Viruses 2017, 9, 220 12 of 12
17. Hoffmann, B.; Scheuch, M.; Hoper, D.; Jungblut, R.; Holsteg, M.; Schirrmeier, H.; Eschbaumer, M.; Goller, K.V.;
Wernike, K.; Fischer, M.; et al. Novel orthobunyavirus in Cattle, Europe, 2011. Emerg. Infect. Dis. 2012, 18,
469–472. [CrossRef] [PubMed]
18. Elliott, R.M.; Blakqori, G.; van Knippenberg, I.C.; Koudriakova, E.; Li, P.; McLees, A.; Shi, X.; Szemiel, A.M.
Establishment of a reverse genetics system for Schmallenberg virus, a newly emerged orthobunyavirus in
Europe. J. Gen. Virol. 2013, 94 Pt 4, 851–859. [CrossRef] [PubMed]
19. Buchholz, U.J.; Finke, S.; Conzelmann, K.K. Generation of Bovine Respiratory Syncytial Virus (BRSV) from
cDNA: BRSV NS2 Is Not Essential for Virus Replication in Tissue Culture, and the Human RSV Leader
Region Acts as a Functional BRSV Genome Promoter. J. Virol. 1999, 73, 251–259. [PubMed]
20. Acrani, G.O.; Tilston-Lunel, N.L.; Spiegel, M.; Weidemann, M.; Dilcher, M.; da Silva, D.E.; Nunes, M.R.;
Elliott, R.M. Establishment of a minigenome system for Oropouche virus reveals the S genome segment to
be significantly longer than reported previously. J. Gen. Virol. 2014, 95, 513–523. [CrossRef] [PubMed]
21. Weber, F.; Dunn, E.F.; Bridgen, A.; Elliott, R.M. The Bunyamwera virus nonstructural protein NSs inhibits
viral RNA synthesis in a minireplicon system. Virology 2001, 281, 67–74. [CrossRef] [PubMed]
22. Shi, X.; Kohl, A.; Li, P.; Elliott, R.M. Role of the cytoplasmic tail domains of Bunyamwera orthobunyavirus
glycoproteins Gn and Gc in virus assembly and morphogenesis. J. Virol. 2007, 81, 10151–10160. [CrossRef]
[PubMed]
23. Moss, B.; Elroy-Stein, O.; Mizukami, T.; Alexander, W.A.; Fuerst, T.R. New mammalian expression vectors.
Nature 1990, 348, 91–92. [CrossRef] [PubMed]
24. Devignot, S.; Bergeron, E.; Nichol, S.; Mirazimi, A.; Weber, F. A virus-like particle system identifies the
endonuclease domain of Crimean-Congo hemorrhagic fever virus. J. Virol. 2015, 89, 5957–5967. [CrossRef]
[PubMed]
25. Strandin, T.; Hepojoki, J.; Vaheri, A. Cytoplasmic tails of bunyavirus Gn glycoproteins—Could they act as
matrix protein surrogates? Virology 2013, 437, 73–80. [CrossRef] [PubMed]
26. Barr, N.J.; Wertz, G.W. Role of the Conserved Nucleotide Mismatch within 3′- and 5′-Terminal Regions of
Bunyamwera Virus in Signaling Transcription. J. Virol. 2005, 79, 3586–3594. [CrossRef] [PubMed]
27. Kohl, A.; Dunn, E.F.; Lowen, A.C.; Elliott, R.M. Complementarity, sequence and structural elements within
the 3′ and 5′ non-coding regions of the Bunyamwera orthobunyavirus S segment determine promoter
strength. J. Gen. Virol. 2004, 85 Pt 11, 3269–3278. [CrossRef] [PubMed]
28. Lowen, A.C.; Elliott, R.M. Mutational analyses of the nonconserved sequences in the Bunyamwera
Orthobunyavirus S segment untranslated regions. J. Virol. 2005, 79, 12861–12870. [CrossRef] [PubMed]
29. Hornak, K.E.; Lanchy, J.-M.; Lodmell, J.S. RNA Encapsidation and Packaging in the Phleboviruses. Viruses
2016, 8. [CrossRef] [PubMed]
30. Dunn, E.F.; Pritlove, D.C.; Jin, H.; Elliott, R.M. Transcription of a recombinant bunyavirus RNA template by
transiently expressed bunyavirus proteins. Virology 1995, 211, 133–143. [CrossRef] [PubMed]
31. Lowen, A.C.; Boyd, A.; Fazakerley, J.K.; Elliott, R.M. Attenuation of bunyavirus replication by rearrangement
of viral coding and noncoding sequences. J. Virol. 2005, 79, 6940–6946. [CrossRef] [PubMed]
32. Mazel-Sanchez, B.; Elliott, R.M. Attenuation of bunyamwera orthobunyavirus replication by targeted
mutagenesis of genomic untranslated regions and creation of viable viruses with minimal genome segments.
J. Virol. 2012, 86, 13672–13678. [CrossRef] [PubMed]
33. Carpenter, S.; Groschup, M.H.; Garros, C.; Felippe-Bauer, M.L.; Purse, B.V. Culicoides biting midges,
arboviruses and public health in Europe. Antivir. Res. 2013, 100, 102–113. [CrossRef] [PubMed]
34. Li, C.-X.; Shi, M.; Tian, J.-H.; Lin, X.-D.; Kang, Y.-J.; Chen, L.-J.; Qin, X.-C.; Xu, J.; Holmes, E.C.; Zhang, Y.-Z.
Unprecedented genomic diversity of RNA viruses in arthropods reveals the ancestry of negative-sense RNA
viruses. eLife 2015, 4. [CrossRef] [PubMed]
35. Dudas, G.; Obbard, D.J. Are arthropods at the heart of virus evolution? eLife 2015, 4. [CrossRef] [PubMed]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
